Advanced search

Direct medical costs of refractory epilepsy incurred by three different treatment modalities: A prospective assessment.

(2002) EPILEPSIA. 43(1). p.96-102
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Boon, Paul, M D’HAVE, P VAN WALLEGHEM, G MICHIELSEN, Kristl Vonck, Jacques Caemaert, and Jacques De Reuck. 2002. “Direct Medical Costs of Refractory Epilepsy Incurred by Three Different Treatment Modalities: A Prospective Assessment.” Epilepsia 43 (1): 96–102.
APA
Boon, Paul, D’HAVE, M., VAN WALLEGHEM, P., MICHIELSEN, G., Vonck, K., Caemaert, J., & De Reuck, J. (2002). Direct medical costs of refractory epilepsy incurred by three different treatment modalities: A prospective assessment. EPILEPSIA, 43(1), 96–102.
Vancouver
1.
Boon P, D’HAVE M, VAN WALLEGHEM P, MICHIELSEN G, Vonck K, Caemaert J, et al. Direct medical costs of refractory epilepsy incurred by three different treatment modalities: A prospective assessment. EPILEPSIA. 2002;43(1):96–102.
MLA
Boon, Paul, M D’HAVE, P VAN WALLEGHEM, et al. “Direct Medical Costs of Refractory Epilepsy Incurred by Three Different Treatment Modalities: A Prospective Assessment.” EPILEPSIA 43.1 (2002): 96–102. Print.
@article{164183,
  author       = {Boon, Paul and D'HAVE, M and VAN WALLEGHEM, P and MICHIELSEN, G and Vonck, Kristl and Caemaert, Jacques and De Reuck, Jacques},
  issn         = {0013-9580},
  journal      = {EPILEPSIA},
  language     = {eng},
  number       = {1},
  pages        = {96--102},
  title        = {Direct medical costs of refractory epilepsy incurred by three different treatment modalities: A prospective assessment.},
  volume       = {43},
  year         = {2002},
}

Web of Science
Times cited: